Cyclerion Therapeutics, Inc. (CYCN)

NASDAQ: CYCN · IEX Real-Time Price · USD

2.930

-0.210 (-6.69%)

At close: Apr 26, 2024, 2:59 PM

3.080

+0.150 (5.12%)

After-hours: Apr 26, 2024, 4:00 PM EDT

Cyclerion Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	0	0.3	3.94	2.3	4.51	0	0	0
Revenue Growth (YoY)	-	-92.47%	71.69%	-49.06%	-	-	-	-
Gross Profit	0	0.3	3.94	2.3	4.51	0	0	0
Selling, General & Admin	8.13	12.86	20.62	28.82	34.4	27.54	15.12	12.65
Research & Development	1.52	5.98	37.64	56.41	95.14	87.72	78.8	50.9
Other Operating Expenses	3.3	0	0.88	-1.67	0	0	0	0
Operating Expenses	12.95	18.84	59.14	83.56	129.54	115.25	93.92	63.55
Operating Income	-12.95	-18.54	-55.2	-81.27	-125.04	-115.25	-93.92	-63.55
Interest Expense / Income	-0.36	-0.29	0.02	-0.59	-2.03	0	0	0
Other Expense / Income	-7.33	25.83	-3.56	-2.88	-	-	-	-
Pretax Income	-5.26	-44.08	-51.65	-77.8	-123.01	-115.25	-93.92	-63.55
Net Income	-5.26	-44.08	-51.65	-77.8	-123.01	-115.25	-93.92	-63.55
Shares Outstanding (Basic)	2	2	2	2	1	1	-	-
Shares Outstanding (Diluted)	2	2	-	-	-	-	-	-
Shares Change	7.59%	0.33%	27.54%	23.64%	76.59%	-	-	-
EPS (Basic)	-2.25	-20.28	-26.40	-51.20	-89.80	-84.20	-	-
EPS (Diluted)	-2.25	-20.28	-26.40	-51.20	-89.80	-84.20	-	-
Free Cash Flow	-21.25	-40.61	-35.06	-72.47	-108.93	-100.94	-82.62	-51.32
Free Cash Flow Per Share	-9.09	-18.69	-16.19	-42.68	-79.31	-129.78	-	-
Gross Margin	-	100.00%	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-	-6242.42%	-1400.18%	-3539.42%	-2774.28%	-	-	-
Profit Margin	-	-14841.08%	-1310.17%	-3388.59%	-2729.27%	-	-	-
Free Cash Flow Margin	-	-13673.74%	-889.40%	-3156.45%	-2416.91%	-	-	-
EBITDA	-5.62	-44.31	-51.16	-76.09	-122.34	-113.72	-92.18	-61.38
EBITDA Margin	-	-14918.18%	-1297.79%	-3314.16%	-2714.38%	-	-	-
Depreciation & Amortization	0	0.07	0.47	2.3	2.7	1.53	1.75	2.17
EBIT	-5.62	-44.37	-51.63	-78.39	-125.04	-115.25	-93.92	-63.55
EBIT Margin	-	-14940.07%	-1309.77%	-3414.20%	-2774.28%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).